Fruquintinib clinical trials in gastric cancer are showing promising results. Will the medicine be approved for this indication soon?

All you need to know about Ogsiveo (nirogacestat) and what it could mean for your desmoid tumor treatment.

Will Zepzelca be available to European and UK patients soon? Here's what we know, and your options if you can't wait.

Can givinostat be used to treat polycythemia vera? Here's what clinical trial data show.

When will the new nonsteroidal treatment for Duchenne be available in the EU and the UK?

When will Joenja be approved (and available) in Europe and the UK? Including how to avoid waiting.

Could Tivdak treat more than cervical cancer? Here's the latest overview of trials focusing on ovarian, head and neck cancers, and more.

When will European patients have access to the newest FDA-approved neuroblastoma treatment?

Iptacopan will soon be approved in Europe, but when will it be available to patients?

Zynyz(retifanlimab) may have a larger role to play in cancer treatment. Find out the latest research in renal cell carcinoma and more.

When will Wainua be available to patients in Europe and the UK? The latest news and all your options in the meantime.

Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?

Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.

Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.

When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.

Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.

Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?

Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.

Tazverik seems a long way from EMA approval. If you can't wait, here are all your options to safely get the treatment.

Stay updated on the latest psoriasis creams approved for children in 2024. Learn about the safest and most effective treatments available for your child's skin condition.

Get the latest updates on Tofersen's EMA approval timeline and discover alternative ways to access the medicine in the meantime.

When will Radicut/Radicava(edaravone) be available to ALS patients in Europe and the UK (and what to do in the meantime).

When is the first nasal spray for dry eyes coming to Europe (and what to do in the meantime)

Topical roflumilast isn't likely to be available in Europe soon. Here's what you can expect, and some solutions for the meantime.

How effective is adagrasib for brain metastases? The latest data, and how to access the treatment quickly.

Adagrasib is now approved in the EU. But it can still take some time until it's available. Here's what you can expect and your options in the meantime.

When are Elahere's EMA and MHRA approvals expected, and what can patients in Europe and the UK do in the meantime.

When will Leqembi receive MHRA approval? And how you can access the medicine in the meantime.

Ryzneuta's EMA and MHRA approvals seem nowhere in sight. Here's how you can access the medicine without waiting.